Viruses are not always something to fear; they can also be tools to heal. This episode looks into this positive side of viral biology.

Dr. Dan Mitchell, Senior Director of Analytical Development and Quality Control at Matica Biotechnology, joins the show to unpack the science and strategy behind viral vector manufacturing in a CDMO environment. He explains what CDMOs do, how they support cell and gene therapy programs at every stage, and why AAV has become such a powerful delivery vehicle. Dan dives deep into analytical development, describing how technologies like qPCR and digital PCR are used to quantify viral genomes, assess empty-to-full ratios, detect residual host cell DNA, and identify rare recombination events. He also discusses how sequencing, infectivity assays, and orthogonal analytics come together to ensure safety, potency, and regulatory readiness.

In Lisa’s Career Corner, Dan traces his path from marine biology curiosity to high-containment virology labs, pressure suits included. He encourages young scientists to get into the lab early, embrace failure as learning, stay curious and find the patience it takes to succeed in science.

Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.

In this episode of Absolute Gene-ius, the hosts dive into the evolving world of precision oncology, where detecting rare molecular signals can make all the difference.

Dr. Kathie Sollweck brings deep expertise from her work in medical affairs and oncology to explain how modern molecular tools are reshaping cancer research. She breaks down liquid biopsy approaches, including cell-free DNA and circulating tumor cells, and explains why sensitivity and pre-analytics are critical when working with low-abundance targets. Kathie also clarifies how sequencing acts as a wide-angle discovery tool, while digital PCR serves as a laser-focused method for ultra-sensitive monitoring of known mutations, therapy resistance, and minimal residual disease (MRD). Together, these technologies enable more personalized, precise, and less invasive cancer monitoring strategies.

The episode wraps with a fun and refreshingly honest Career Corner, where Kathie shares her non-linear journey from an aspiring actress to botanist to oncology expert. Her advice? Don’t fear sales roles, stay open to unexpected opportunities, and let curiosity guide your career because you never know where it might take you.

Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.

PCR inhibitors are everywhere and they can definitely mess with your data. From muddy lake water to complex viral vector preparations, inhibition is a reality that can’t be ignored.

In this inaugural Absolute Gene-ius: Science Snapshot, hosts Jordan Ruggieri and Lisa Crawford revisit standout moments from past seasons to explore how scientists across disciplines deal with PCR inhibition. Through clips from experts working in wastewater surveillance, environmental microbiology, and gene therapy manufacturing, the episode highlights why inhibitors distort qPCR results and how sample preparation alone doesn’t always solve the problem. Guests including Ray Ketchum, Sarah Philo, Patrick Hanington, Dave Bauer, Kimberly Gomez, and Min Jin Kim explain both the biological sources of inhibition and the technical reasons digital PCR is more resilient. Together, these perspectives paint a clear picture of why dPCR is becoming the method of choice when overcoming inhibitors is required.

Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.